Monaldi Archives for Chest Disease最新文献

筛选
英文 中文
Efficacy and safety of colchicine in patients with myocardial infarction: a systematic review and meta-analysis. 秋水仙碱对心肌梗死患者的疗效和安全性:一项系统回顾和荟萃分析。
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-09-02 DOI: 10.4081/monaldi.2026.3897
Muhammad Furqan Saleem, Tuba Ashraf, Ahmed Mekki, Usama Siddique, Muhammad Usama Javed, Chaudhry Bilal Rauf, Chaudhary Hammad Jamil, Azaz Ali Shah, Muhammad Usman Haider, Salman Ahsan, Mohammad Ebad Ur Rehman, Huzaifa Ahmad Cheema, Bilawal Nadeem, Raheel Ahmed
{"title":"Efficacy and safety of colchicine in patients with myocardial infarction: a systematic review and meta-analysis.","authors":"Muhammad Furqan Saleem, Tuba Ashraf, Ahmed Mekki, Usama Siddique, Muhammad Usama Javed, Chaudhry Bilal Rauf, Chaudhary Hammad Jamil, Azaz Ali Shah, Muhammad Usman Haider, Salman Ahsan, Mohammad Ebad Ur Rehman, Huzaifa Ahmad Cheema, Bilawal Nadeem, Raheel Ahmed","doi":"10.4081/monaldi.2026.3897","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3897","url":null,"abstract":"<p><p>Colchicine is an anti-inflammatory drug that has emerged as a potential treatment option following myocardial infarction (MI). This meta-analysis assesses the efficacy and safety of colchicine in patients following an MI. A comprehensive literature search was performed using the Cochrane Library, ClinicalTrials.gov, Embase, and MEDLINE, covering studies from their inception to December 2025. RevMan was used to perform a random-effects meta-analysis, and forest plots were used to visualize pooled estimates. The Mantel-Haenszel method was applied to analyze dichotomous outcomes. Nine randomized control trials (RCTs) were included in this meta-analysis, including 13,834 patients. The analysis revealed that there was no statistically significant difference between colchicine and placebo groups in all-cause mortality [relative risk (RR)=0.93, confidence interval (CI)=0.78-1.11], cardiac death (RR=0.95, CI=0.73-1.22), MI (RR=0.82, CI=0.67-1.00), stroke (RR=0.64, CI=0.26-1.58), adverse events (RR=1.01, CI=0.85-1.21),  serious adverse events (RR=0.96, CI=0.87-1.05), serious gastrointestinal adverse events (RR=1.35, CI=0.94-1.95), and serious infections (RR=1.00, CI=0.62-1.62). However, there was an increased risk of diarrhea in people with colchicine compared to the placebo (RR=2.12, CI=1.35-3.32). This meta-analysis demonstrates that colchicine following an MI does not have a significant impact on cardiovascular events or major adverse events other than an increased risk of diarrhea. There is a need for more comprehensive RCTs with longer follow-up times to fully comprehend the potential cardiovascular benefits of colchicine.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148882103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Agreement between apnea-hypopnea index and hypoxic burden for severity classification of obstructive sleep apnea. 呼吸暂停低通气指数与缺氧负担对阻塞性睡眠呼吸暂停严重程度分级的一致性。
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-08-26 DOI: 10.4081/monaldi.2026.4016
Muhammad Salik, Muhammad Saad, William S Burkes
{"title":"Agreement between apnea-hypopnea index and hypoxic burden for severity classification of obstructive sleep apnea.","authors":"Muhammad Salik, Muhammad Saad, William S Burkes","doi":"10.4081/monaldi.2026.4016","DOIUrl":"https://doi.org/10.4081/monaldi.2026.4016","url":null,"abstract":"<p><p>This study aimed to evaluate the agreement between apnea-hypopnea index (AHI)- and hypoxic burden (HB)-based obstructive sleep apnea (OSA) severity classifications. A retrospective single-center study of adults aged 18-79 years undergoing full-night in-laboratory polysomnography was conducted. OSA severity by AHI was categorized as normal (<5 events/hour), mild (5 to <15), moderate (15 to <30), or severe (≥30). HB severity was categorized as mild (<3.34), moderate (3.34 to 6.66), or severe (≥6.67). Agreement among patients with OSA (AHI ≥5) was assessed using Cohen's kappa. Ninety-five patients were included (mean age 58.4±18.3 years); 73 (76.8%) had OSA. Among these, HB severity exceeded AHI severity in 27.4%, was concordant in 61.6%, and was lower in 11.0%. Observed agreement was 30.1%, with slight concordance beyond chance (κ=0.168, p<0.001). Continuous AHI and HB were moderately correlated (r=0.663, p<0.001). Patients with HB greater than AHI severity demonstrated significantly lower nadir oxygen saturation (p=0.011). AHI- and HB-based OSA severity classifications demonstrate limited agreement. Incorporation of HB may provide a more physiologically informative assessment of OSA severity beyond event frequency alone.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148834629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic yield of thoracoscopic pleural biopsy in undiagnosed exudative pleural effusion and comparative analysis of pleural fluid adenosine deaminase levels. 胸腔镜胸膜活检对未确诊的渗出性胸腔积液的诊断率及胸膜液腺苷脱氨酶水平的比较分析。
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-08-25 DOI: 10.4081/monaldi.2026.3910
Deepak Sharma, Sachin Kumar, Ved Prakash, Mohammad Arif, Anurag Tripathi, Shubhra Srivastava, Hemant Kumar, Mrityunjaya Singh, Harshita Mishra
{"title":"Diagnostic yield of thoracoscopic pleural biopsy in undiagnosed exudative pleural effusion and comparative analysis of pleural fluid adenosine deaminase levels.","authors":"Deepak Sharma, Sachin Kumar, Ved Prakash, Mohammad Arif, Anurag Tripathi, Shubhra Srivastava, Hemant Kumar, Mrityunjaya Singh, Harshita Mishra","doi":"10.4081/monaldi.2026.3910","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3910","url":null,"abstract":"<p><p>Undiagnosed exudative pleural effusion remains a frequent clinical challenge, particularly in high-burden settings where tuberculosis and malignancy predominate. Pleural fluid adenosine deaminase (ADA) is useful for suggesting tuberculous pleural effusion (TPE), but a substantial \"gray zone\" overlaps with malignant pleural effusion (MPE). This study evaluated the diagnostic yield of medical thoracoscopy with comparative analysis of pleural fluid ADA levels. This prospective, single-center, exploratory observational study was conducted over 1.5 years in a tertiary care hospital of north India. Consecutive adults (>18 years) with undiagnosed exudative pleural effusion (Light's criteria) were enrolled after pleural fluid CBNAAT/GeneXpert was negative for Mycobacterium tuberculosis and pleural fluid cytology negative for malignancy on at least two samples, taken ≥24 hours apart. A total of 150 patients were included (92 males, 58 females). All patients underwent single-port medical thoracoscopy under conscious sedation, systematic pleural inspection, and targeted biopsy (3-6 samples). Biopsies were sent for histopathology and CBNAAT. Thoracoscopic pleural biopsy established malignancy in 104/150 (69.3%) and tuberculosis in 40/150 (26.7%) patients, resulting in an overall diagnostic yield of 96%. Non-specific inflammation was observed in four patients, pyogenic inflammation in one, and one biopsy was inconclusive. Metastatic adenocarcinoma was the commonest malignancy (88/104). In biopsy-proven TPE, tissue CBNAAT positivity was low (9/40, 22.5%). ADA was significantly higher in tubercular effusions than MPE (40.17 vs. 20.11 IU/L; p<0.001). Major complications were infrequent with no procedure-related mortality.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148820290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between early weight variation and treatment outcomes among extensively drug-resistant tuberculosis patients in Pakistan: a multicenter retrospective cohort study. 巴基斯坦广泛耐药结核病患者早期体重变化与治疗结果之间的关系:一项多中心回顾性队列研究
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-08-25 DOI: 10.4081/monaldi.2026.4000
Muhammad Abubakar, Javeria Sehar, Rimsha Mukhtar
{"title":"Association between early weight variation and treatment outcomes among extensively drug-resistant tuberculosis patients in Pakistan: a multicenter retrospective cohort study.","authors":"Muhammad Abubakar, Javeria Sehar, Rimsha Mukhtar","doi":"10.4081/monaldi.2026.4000","DOIUrl":"https://doi.org/10.4081/monaldi.2026.4000","url":null,"abstract":"<p><p>Tuberculosis (TB) is commonly associated with significant weight loss, and weight gain during treatment is often considered an indicator of treatment response. However, evidence regarding the association between weight change and treatment outcomes among patients with extensively drug-resistant TB (XDR-TB) remains limited. This study aimed to evaluate the relationship between weight change during treatment and treatment outcomes among XDR-TB patients in Pakistan. A multicenter retrospective cohort study was conducted using data from XDR-TB patients treated at 27 Programmatic Management of Drug-Resistant TB units across Pakistan between May 2010 and June 2019. Patient data were extracted from the Electronic Nominal Recording and Reporting System of the National Tuberculosis Control Program. Weight change was assessed at 2, 4, and 6 months of treatment and categorized as no weight gain, weight gain <4 kg, and ≥4 kg. Logistic regression analysis was performed to determine the association between weight gain and favorable treatment outcomes. A total of 255 XDR-TB patients were included in the final analysis. Among them, 54.9% were male, and the majority (52.2%) belonged to the 21-40 year age group. Overall, favorable treatment outcomes were observed in 54.9% of patients. In multivariate analysis, weight gain at the fourth month of treatment showed a statistically significant negative association with favorable treatment outcomes for both weight gain <4 kg (OR 0.343, p=0.039) and ≥4 kg (OR 0.370, p=0.020). No statistically significant association was observed between weight gain at two or six months and treatment outcomes. These findings suggest that weight gain during treatment may not be a reliable predictor of favorable treatment outcomes among XDR-TB patients, and additional clinical and microbiological indicators should be considered when monitoring treatment response.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148820280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between cancer-related worry and intention to quit smoking among Turkish smokers: a cross-sectional study. 在土耳其吸烟者中,癌症相关担忧与戒烟意图之间的关系:一项横断面研究。
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-08-06 DOI: 10.4081/monaldi.2026.3828
Hatice Tuba Akbayram, Zekiye Temizkan
{"title":"Association between cancer-related worry and intention to quit smoking among Turkish smokers: a cross-sectional study.","authors":"Hatice Tuba Akbayram, Zekiye Temizkan","doi":"10.4081/monaldi.2026.3828","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3828","url":null,"abstract":"<p><p>Concerns about getting cancer may increase the desire to quit smoking in smokers. This study was conducted to determine the level of cancer worry in smokers and the relationship between cancer worry and intention to quit smoking. An online survey was administered to smokers aged 18 years and older without a history of cancer between January and February 2025. The questionnaire included questions about socio-demographic characteristics, the Fagerstrom Test for Nicotine Dependence (FTND), the Cancer Worry Scale (CWS) and the Smoking Cessation Intention Scale (SCIS). The mean age of the participants (n=321) was 33.72 years, and the majority were male (75.1%). Mean scores for FTND, CWS, and SBNS were 4.82±3.16, 15.69±5.02, and 28.11±8.39, respectively. High levels of cancer concern (CWS≥14) were found in 67.3% of smokers. A statistically significant, moderate positive correlation was found between CWS and SCIS scores (r=0.362, p<0.001). Participants' SCIS scores were significantly higher among individuals who were 30 years or older compared to younger participants, in married individuals compared to their unmarried counterparts, and in those with a high level of cancer worry compared to those with a low level of worry. Participants with a high cancer worry level were significantly more likely to think about quitting smoking in the next year than participants with a low worry level (p=0.027). The findings show the positive effect of increased cancer worry on the intention to quit smoking. Increased awareness about cancer may increase motivation to quit smoking.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atherogenic dyslipidemia as a novel cardiovascular risk stratification tool in chronic obstructive pulmonary disease: a hospital-based cross-sectional study. 动脉粥样硬化性血脂异常是慢性阻塞性肺疾病中一种新的心血管危险分层工具:一项基于医院的横断面研究
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-08-06 DOI: 10.4081/monaldi.2026.3802
Sanchit Mehta, Rajvi Kalpesh Baxi, Parina Manish Rathi, Hetvi Rajesh Pabari, Dhairya Hitesh Shah, Pratik Raghavani, Ajay Rajput
{"title":"Atherogenic dyslipidemia as a novel cardiovascular risk stratification tool in chronic obstructive pulmonary disease: a hospital-based cross-sectional study.","authors":"Sanchit Mehta, Rajvi Kalpesh Baxi, Parina Manish Rathi, Hetvi Rajesh Pabari, Dhairya Hitesh Shah, Pratik Raghavani, Ajay Rajput","doi":"10.4081/monaldi.2026.3802","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3802","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) is characterized by progressive airway obstruction and systemic inflammation, frequently accompanied by metabolic comorbidities, including dyslipidemia. The Atherogenic Index of Plasma (AIP), calculated as log10[triglycerides/high-density lipoprotein (HDL)-cholesterol], is strongly associated with atherosclerotic cardiovascular disease risk, yet its relationship with COPD-associated dyslipidemia remains underexplored. This study investigates the association between atherogenic dyslipidemia profiles and COPD duration, utilizing AIP as an evaluation metric. A hospital-based cross-sectional analytical study was conducted among 100 COPD patients without acute exacerbations. Fasting serum lipid profiles were analyzed using standardized protocols, and AIP was calculated for each participant. Patients were stratified into three AIP risk categories: low risk (AIP<0.21), moderate risk (AIP 0.21-0.5), and high risk (AIP>0.5). Associations between COPD duration, smoking status, demographic variables, and lipid parameters were examined using chi-square analysis. 60% of COPD patients demonstrated high atherogenic index profiles (AIP>0.5), indicating substantial cardiovascular risk. A significant positive correlation was found between COPD duration and AIP (r=0.456, p<0.001), as well as with triglycerides (r=0.341, p<0.001) and low-density lipoprotein-cholesterol (r=0.405, p<0.001). Conversely, COPD duration demonstrated a nonsignificant trend toward an inverse correlation with HDL-cholesterol (r=-0.173, p=0.089). Seventy-one percent of patients demonstrated low HDL-cholesterol (<40 mg/dL). Smoking status was significantly associated with elevated very low-density lipoprotein-cholesterol (p=0.002). The high prevalence of atherogenic dyslipidemia in COPD patients, as quantified by AIP, suggests that lipid profile alteration is progressive and correlates with disease duration. AIP represents a clinically relevant, cost-effective screening tool for identifying COPD patients at elevated cardiovascular risk, facilitating early intervention and personalized risk stratification strategies.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of pleural fluid biomarkers in differentiating malignant and benign pleural effusion: a cross-sectional study. 胸水生物标志物在鉴别恶性和良性胸腔积液中的应用:一项横断面研究。
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-08-06 DOI: 10.4081/monaldi.2026.3731
Nishant Kumar Chauhan, Yogendra Singh Rathore, Mithu Banerjee, Naveen Dutt, Gopal Durgeshwar, Iyer Hariharan
{"title":"Utility of pleural fluid biomarkers in differentiating malignant and benign pleural effusion: a cross-sectional study.","authors":"Nishant Kumar Chauhan, Yogendra Singh Rathore, Mithu Banerjee, Naveen Dutt, Gopal Durgeshwar, Iyer Hariharan","doi":"10.4081/monaldi.2026.3731","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3731","url":null,"abstract":"<p><p>As cytopathological examination of the pleural fluid (PF) has a low yield, it is difficult to differentiate benign from malignant pleural effusions (PEs). There is still a lack of biomarkers in PF that can reliably help in diagnosing malignant PEs. Diagnostic accuracy in diagnosing malignant PEs is enhanced by the presence of tumor markers in PE. This would raise the likelihood of diagnosing malignant PEs with an unclear cause and starting treatment interventions early to lower morbidity and death rates in the patient. Thus, in an effort to enhance the PE diagnosis, novel PF biomarkers such as cancer ratio, cancer ratio plus, carcinoembryonic antigen (CEA), cancer antigen 125 (CA-125), and calprotectin were evaluated. A total of 108 patients with PEs were taken, and after applying inclusion and exclusion criteria, 83 patients with exudative PE were evaluated. After clinical history and routine blood investigations, PF was sent for cytopathology, biochemical examinations, microbiological examinations for aerobic culture, fungal culture, mycobacterial culture, and biomarker (CEA, CA-125, calprotectin) analyses. Out of 83 patients with exudative PE, malignant effusion was diagnosed in 40 patients, while 43 had benign effusions. PF biomarkers adenosine deaminase (ADA), CEA, cancer ratio, calprotectin, age/ADA and serum lactate dehydrogenase (LDH)/calprotectin ratio showed a statistically significant (p<0.0001) difference between benign and malignant PE. PF CEA showed the highest specificity (97.67%) at the cut-off point of 1.96 ng/mL and age/ADA ratio showed the highest sensitivity (97.5%) at the cut-off point of 1.56 for prediction of malignancy. Cancer ratio, PL calprotectin and serum LDH/calprotectin ratio also showed good sensitivity and specificity for the prediction of malignancy. PF CA-125 showed poor sensitivity (50%) and cancer ratio plus did not reveal any statistically significant difference for prediction of malignancy from benign effusion (p=0.486). PF biomarkers (cancer ratio, CEA, age/ADA ratio, calprotectin, and serum LDH/calprotectin ratio) are reliable indicators of malignancy in exudative pleural effusions. Patients with exudative lymphocytic with unexplained pleural effusion can be addressed early using inexpensive and generally available biochemical indicators, such as pleural fluid CEA, calprotectin, cancer ratio, and serum LDH/calprotectin ratio.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond vascular endothelial growth factor: synergistic diagnostic value of multiple biomarkers in malignant pleural effusion. A cross-sectional analytical study. 血管内皮生长因子以外:多种生物标志物在恶性胸腔积液中的协同诊断价值。横断面分析研究。
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-08-05 DOI: 10.4081/monaldi.2026.3688
Ngakan Putu Parsama Putra, Anthony Christanto, Muhammad Iqbal, Adlan Pratama Binharyanto, Cleine Michaela, Mohammad Faridza Setyohadikusumah
{"title":"Beyond vascular endothelial growth factor: synergistic diagnostic value of multiple biomarkers in malignant pleural effusion. A cross-sectional analytical study<b />.","authors":"Ngakan Putu Parsama Putra, Anthony Christanto, Muhammad Iqbal, Adlan Pratama Binharyanto, Cleine Michaela, Mohammad Faridza Setyohadikusumah","doi":"10.4081/monaldi.2026.3688","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3688","url":null,"abstract":"<p><p>Malignant pleural effusion (MPE) remains a challenging diagnostic entity within the vast spectrum of pleural effusions. While vascular endothelial growth factor (VEGF) is a widely studied MPE biomarker, its diagnostic performance as a standalone marker is limited. There is growing interest in evaluating whether combined biomarker panels may provide incremental diagnostic information and reduce diagnostic uncertainty. This study aims to explore whether integrating matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1 (TIMP-1), and monocyte chemoattractant protein-1 (MCP-1) into VEGF provides incremental diagnostic value in distinguishing malignant from benign pleural effusions. A total of 88 pleural fluid samples were analyzed (33 malignant, 55 benign). Biomarker levels were measured using enzyme-linked immunosorbent assay. Diagnostic performance was assessed via receiver operating characteristic analysis, with optimal cut-off values identified using the Youden Index. Logistic regression models were developed for combined biomarker panels and internally validated using 5-fold cross-validation. VEGF demonstrated moderate individual diagnostic value (area under the curve 0.640; sensitivity 72.7%; specificity 58.2%; and diagnostic odds ratio of 3.71). Other individual markers showed limited accuracy. The four-marker panel (VEGF + MMP-9 + TIMP-1 + MCP-1) showed a modest increase in sensitivity, negative predictive value, and diagnostic odd ratio, although specificity remains limited. These findings suggest that combined pleural fluid biomarkers may provide incremental diagnostic information, but their performance remains modest and requires external validation before clinical application.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic predictors of tuberculosis in exudative pleural effusion patients with intermediate adenosine deaminase values: a retrospective diagnostic prediction model study. 具有中等腺苷脱氨酶值的渗出性胸腔积液患者结核的诊断预测因素:回顾性诊断预测模型研究。
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-08-05 DOI: 10.4081/monaldi.2026.3828
Gautam Prem, Dimple Kumar Bhaglani, R S Negi, Surya Tej P V, Himmat Singh Pannu
{"title":"Diagnostic predictors of tuberculosis in exudative pleural effusion patients with intermediate adenosine deaminase values: a retrospective diagnostic prediction model study.","authors":"Gautam Prem, Dimple Kumar Bhaglani, R S Negi, Surya Tej P V, Himmat Singh Pannu","doi":"10.4081/monaldi.2026.3828","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3828","url":null,"abstract":"<p><p>Adenosine deaminase (ADA) in pleural fluid is widely used to support the diagnosis of tuberculous pleural effusion. However, ADA levels between 40 and 60 IU/L represent a gray area where both tuberculous and non-tuberculous conditions can coexist. It can potentially lead to empirical antitubercular therapy and a delay in the diagnosis of other conditions. The aim of this study was to create and validate a prediction model to improve the diagnosis of tuberculosis (TB) in patients with exudative pleural effusions and intermediate ADA levels. This retrospective diagnostic modeling study included 125 consecutive adults with exudative pleural effusions, meeting Light's criteria, and pleural fluid ADA levels between 40 and 60 IU/L. These patients were referred to a tertiary respiratory care center in northern India. Univariable receiver operating characteristic curve analysis was used to shortlist candidate predictors with an area under the curve (AUC) of ≥0.60 and p≤0.05. A multivariable logistic regression model was developed using the forward stepwise procedure, including ADA, pleural fluid protein, and patient age. The performance of the model was assessed for discrimination, calibration, and classification and compared to the performance of ADA alone. Internal validation was done using 10-fold stratified cross-validation. Of 125 patients, 77 (62%) had TB and 48 (38%) had non‑TB aetiologies (malignancy ≈30%; acute inflammatory/parapneumonic effusion ≈12%; chronic inflammatory conditions ≈6%). The 3‑predictor model achieved an AUC of 0.89 [95% confidence interval (CI) 0.83-0.95] and an overall accuracy of 85%, with sensitivity 89%, specificity 79%, positive predictive value 84% and negative predictive value 86% at a probability cut‑off of 0.50. ADA alone yielded an AUC of 0.72 (95% CI 0.62-0.82) and accuracy of 68%, with sensitivity 70% and specificity 65%. Ten‑fold stratified cross‑validation showed stable performance (mean cross‑validated AUC 0.87±0.04; optimism 0.02). Independent predictors were ADA [odds ratio (OR) 1.24 per IU/L], protein (OR 1.65 per g/dL) and age (OR 0.93 per year; all p<0.001). In exudative pleural effusions with an ADA level of intermediate values, a simple model combining ADA, pleural protein concentration, and patient age improves the diagnostic discrimination for TB over ADA alone, with a marked improvement in negative predictive probability. External validation in a prospective multicenter study is needed before its use in clinical practice.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing unmet needs in uncontrolled asthma through a specialized severe asthma center. 通过专门的严重哮喘中心解决未满足的未控制哮喘需求。
IF 0.8
Monaldi Archives for Chest Disease Pub Date : 2026-08-05 DOI: 10.4081/monaldi.2026.3908
Francesco Ardesi, Paolo Delvino, Marco Vanetti, Martina Zappa, Patrizia Pignatti, Rosella Centis, Veronica Capuano, Alessandro Maria Marra, Francesco Bini, Stefania Gallo, Giulia Franzini, Daniela Gallo, Eliana Piantanida, Nicola Sverzellati, Antonio Spanevello, Dina Visca
{"title":"Addressing unmet needs in uncontrolled asthma through a specialized severe asthma center<b />.","authors":"Francesco Ardesi, Paolo Delvino, Marco Vanetti, Martina Zappa, Patrizia Pignatti, Rosella Centis, Veronica Capuano, Alessandro Maria Marra, Francesco Bini, Stefania Gallo, Giulia Franzini, Daniela Gallo, Eliana Piantanida, Nicola Sverzellati, Antonio Spanevello, Dina Visca","doi":"10.4081/monaldi.2026.3908","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3908","url":null,"abstract":"<p><p>Severe asthma represents a clinically challenging proportion of the asthma population, characterized by persistent symptoms, frequent exacerbations, and a higher healthcare burden. To address the complexity of uncontrolled disease, specialized severe asthma clinics have emerged as key models for delivering precision medicine through multidimensional assessment and tailored interventions. This paper describes the organization, clinical approach, and multidisciplinary framework of a tertiary Severe Asthma Centre established in Northern Italy in 2017. The center integrates prioritized outpatient access with a structured day-hospital program (Complex Outpatient Macro Activity, MAC), enabling accelerated diagnostic work-up, comprehensive phenotyping/endotyping, and repeated educational interventions. Central elements include confirmation of diagnosis, assessment of type 2 inflammatory biomarkers (FeNO, IgE, blood and sputum eosinophils), evaluation of airway inflammation, and systematic identification of pulmonary and extrapulmonary treatable traits. A broad multidisciplinary network supports the management of comorbidities such as allergic rhinitis, chronic rhinosinusitis, hypereosinophilic disorders, allergic bronchopulmonary aspergillosis, metabolic and endocrine complications, gastroesophageal reflux disease, and vocal cord dysfunction. Pulmonary rehabilitation is integrated as an adjunctive intervention, particularly for patients with severe disease. Our severe asthma clinic implements precision medicine and the treatable traits approach in clinical practice to optimize outcomes, rationalize biologic therapy use, and reduce glucocorticoid exposure. Future perspectives include expansion toward a \"united airways disease\" clinic, integrating upper and lower airway management to further improve care for complex inflammatory airway diseases.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书